Satisfaction and continuation with LNG-IUS 12: findings from the real-world kyleena® satisfaction study.
Dale W StovallKeith AquaThomas RömerGilbert DondersTerje SørdalBrian HauckEric Saucedo de la LlataHelena Kopp KallnerJulie SalomonMichal ZvolanekAnn-Kathrin FrenzTanja BöhnkeAnja BauerfeindPublished in: The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception (2021)
Results from KYSS provide the first real-world evidence assessing LNG-IUS 12, and demonstrate high satisfaction and continuation rates irrespective of age or parity. Clinical trial registration: NCT03182140.